(Q53243856)
Statements
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. (English)
Jose Baselga
1 reference
Michael Untch
1 reference
Mitch Dowsett
1 reference
Andrea Feyereislova
Aron Goldhirsch
Marion Procter
Nadia Harbeck
Ian Smith
Richard D Gelber
Sébastien Guillaume
Manfred Kaufmann
David Cameron
Richard Bell
Jonas Bergh
Robert Coleman
Roberto I Lopez
Peter Mallmann
Karen Gelmon
Nicholas Wilcken
Erik Wist
Pedro Sánchez Rovira
Martine J Piccart-Gebhart
HERA study team
1 January 2007
369
9555
29-36